Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Validated assay for anticancer drug screening
April 2010
SHARING OPTIONS:

Trevigen Inc.
Trevigen has introduced the HT PARP in vivo Pharmacodynamic Assay II, a validated assay with higher sensitivity and pre-coated antibody plates to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening. The improved assay features pre-coated capture antibody plates; broad linear dynamic range to 1,000 pg/ml; high signal-to-noise ratio; and detection sensitivity of 2 pg/ml of PAR. The amount of PAR present correlates directly with the activity of the PARP enzyme in cell lysates. The assay is ideal for quantification of PAR in peripheral blood mononuclear cells, tissues and cultured cells.

Trevigen Inc.
(800) 873-8443
www.trevigen.com 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.